Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.07M | $222.0M | 7.46% | +2.87M | 2026-06-30 |
| STATE STREET CORP | 13.00M | $191.0M | 6.44% | +4.60M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.23M | $121.0M | 4.07% | +700.2K | 2026-06-30 |
| Anson Funds Management LP | 7.15M | $105.0M | 3.54% | +1.11M | 2026-06-30 |
| CITADEL ADVISORS LLC | 6.61M | $97.0M | 3.27% | +1.72M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.88M | $72.0M | 2.42% | +971.6K | 2026-06-30 |
| JONES FINANCIAL COMPANIES LLLP | 2.30M | $28.0M | 1.14% | +629.5K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.16M | $31.0M | 1.07% | +698.3K | 2026-06-30 |
| NORTHERN TRUST CORP | 1.62M | $23.0M | 0.80% | +343.9K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 1.50M | $22.0M | 0.74% | -- | 2026-06-30 |
